In Vivo Observation of Leukocyte-Endothelium Interaction in Ischemia Reperfusion Injury With the Dorsal Window Chamber and the Effects of Pentoxifylline on Reperfusion Injury

Journal of Surgical Research

Volumn 138, Issue 2, 2007, Pages 259-266

  Unal, Cigdem ^a   Sen, Cenk ^a   Iscen, Deniz ^a   Dalcik, Hakki ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

in vivo, pentoxifylline; ischemia reperfusion injury; leukocyte endothelium interaction; window chamber

Indexed keywords

ACRIDINE; PENTOXIFYLLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL DAMAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; ISCHEMIA; LEUKOCYTE; MICROSURGERY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VEIN; VENULE; VIDEORECORDING;

ANIMALS; CATHETERIZATION; CELL COMMUNICATION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; LEUKOCYTE ROLLING; LEUKOCYTES; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; PENTOXIFYLLINE; PROSTHESES AND IMPLANTS; RATS; RATS, WISTAR; REPERFUSION INJURY; VASODILATOR AGENTS; VENULES;

EID: 33847622143     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.05.019     Document Type: Article

References (51)

1. Siemionow M., and Arslan E. Ischemia/reperfusion injury: A review in relation to free tissue transfers. Microsurgery 24 (2004) 468
2. 2 in postischemic "no reflow", and "reflow paradox". J Surg Res. 120 (2004) 1
3. Endrich B., Asaishi K., Götz A., and Messmer K. Technical report: A new chamber technique for microvascular studies in unanesthetised hamsters. Res Exp Med 117 (1980) 125
4. Lehr H.A., Leunig M., Menger M.D., Nolte D., and Messmer K. Dorsal skinfold chamber for technique for intravital microscopy on striated muscle in nude mice. Am J Pathol 143 (2000) 1055
5. Frank J., Gorantia V.S., Anderson G.L., Perez L.L., Maldonado C., and Barker J.H. Microcirculation research for microsurgeons: Basic concept and potential applications. Eur J Trauma 27 (2001) 153
6. Müller J.M., Vollmar B., and Menger M. Pentoxifylline reduces venular adherence ("reflow paradox") but not microvascular "no reflow" in hepatic ischemia reperfusion. J Surg Res 71 (1997) 1
7. Ward A., and Clissold S.P. Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic properties, and its therapeutic efficacy. Drugs 34 (1987) 50
8. Mollitt D.L., and Poulos N.D. The role of pentoxifylline in endotoxin induced alterations of red blood cell deformability and whole blood viscosity in the neonate. J Pediatr Surg 26 (1991) 572
9. Badger A.M., Olivera D.L., and Esser K.M. Beneficial effects of the phosphodiesterase inhibitors BRL61063, pentoxifylline and rollipram in a murine model ofendotoxin shock. Circ Shock 44 (1994) 188
10. Barton M.H., and Moore J.N. Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia. Circ Shock 44 (1994) 216
11. Nakagawa K., Miller F., Knott A.W., and Edwards M.J. Pentoxiphylline inhibits FMLP induced macromolecular leakage. Am J Physiol 269 (1995) H239
12. Papenfuss H.D., Gross J.F., İntaglietta M., and Treese F.A. A transparent access chamber for the rat dorsal skin fold. Microvasc Res 18 (1979) 311
13. Menger M.D., Barker J.H., and Messmer K. Capillary blood perfusion during postischemic reperfusion in striated muscle. Plast Reconstr Surg 89 (1992) 1104
14. Grace P.A. Ischemia reperfusion injury. Br J Surg 81 (1994) 637
15. Menger M.D., Pelikan S., Steiner D., and Messmer K. Microvascular ischemia reperfusion injury in striated muscle: Significance of "reflow paradox". Am J Physiol 263 Pt 2 (1992) 1901
16. Grisham M.B., Granger D.N., and Lefer D.J. Modulation of leukocyte endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease. Free Radicals Biol Med 25 (1998) 404
17. Menger M.D., Steiner D., and Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: Significance of "no-reflow". Am J Physiol (Heart Circ Physiol 32) 263 (1992) H1892
18. Granger D.N. Role of xanthine oxidase and granulocytes in ischemia reperfusion injury. Am J Physiol 255 (1988) H1269
19. Menger M.D., Lehr H.A., and Messmer K. Role of oxygen radicals in the microcirculatory manifestations of postischemic injury. Klin Wochenschr 69 (1991) 1050
20. Skoglund G., Cotgrave I., Rincon J., Patarroyo M., and Ingelman-Sundberg M. H2O2 activates CD 11/CD18 dependent cell adhesions. Biochem Biophys Res Commun 157 (1988) 443
21. Patel K.D., Zimmermann G.A., Prescott S.M., Mcever R.P., and McIntyre T.M. Oxygen radicals induce human endothelial cells to express GMP 140 and bind neutrophils. J Cell Biol 112 (1991) 749
22. Granger D.N., and Kubes P. The microcirculation and inflammation: Modulation of leukocyte endothelial cell adhesion. J Leukoc Biol 655 (1994) 62
23. Schall T.J., and Bacon K.B. Chemokines, leukocyte trafickking and inflammation. Curr Opin Immunol 6 (1994) 865
24. Jassem W., and Roake J. The molecular and cellular basis of reperfusion injury following organ transplantation. Transplant Rev 12 (1998) 14
25. Carden D.L., Smith J.K., and Korthius R.J. Neutrophil mediated microvascular dysfunction in postischemic canine skeletal muscle: Role of granulocyte adherence. Circ Res 66 (1990) 1436
26. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365
27. Bagge U., Amundson B., and Lauritzen C. White blood cell deformability and plugging of skeletal muscle capillaries in hemorrhagic shock. Acta Physiol Scand 108 (1980) 159
28. Fantone J.C., and Ward P.A. Role of oxygen derived free radicals and metabolites in leukocyte dependent inflammatory reactions. Am J Pathol 107 (1982) 394
29. Carroll W.R., and Esclamado R.M. Ischemia reperfusion injury in microvascular surgery. Head Neck 22 (2000) 700
30. Kakkar A.K., and Lefer D.J. Leukocyte and endothelial adhesion molecule studies in knockout mice. Curr Opin Pharmacol 4 (2004) 154
31. Arnlgots B., Dougan P., and Bergqvist D. Anti-thrombotic and platelet activating effects of heparin in prevention of microarterial thrombosis. Plast Reconstr Surg 99 (1997) 1122
32. Wolfort S.F., Angel M.F., Knight K.R., Amiss L.R., and Morgan R.F. The beneficial effect of dextran on anastomotic patency and flap survival in a strongly thrombogenic model. J Reconstr Microsurg 8 (1992) 375
33. Buckley R.C., Davidson S.F., and Doss S.K. The role of various anti-thrombotic agents in microvascular surgery. Br J Plast Surg 47 (1994) 20
34. Slater C., and House S.D. The effects of non-steroidal anti-inflammatory drugs on microvascular dynamics. Microvasc Res 45 (1993) 166
35. Russell R.C., Roth A.C., Kucan J.O., and Zook E.G. Reperfusion injury and oxygen free radicals: A review. J Reconstr Microsurg 5 (1989) 79
36. Knight K.R. Review of postoperative pharmacological infusions in ischemic skin flaps. Microsurgery 15 (1994) 675
37. Knight K.R., Kawabata H., Coe S.A., Angus J.A., O'Brien B.M., and Sakai K. Oxrotacyclin and prostanoid modifiers aid ischemic skin flap survival. J Surg Res 50 (1991) 119
38. Lee H.T., and Lineaweaver W.C. Protection against ischemic-reperfusion injury of skeletal muscle: Role of ischemic preconditioning and Adenosine pretreatment. J Reconstr Microsurg 12 (1996) 383
39. Ehrly A.M. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease. J Med 10 (1979) 331
40. Mandel G.L. ARDS, neutrophils, and pentoxifylline. Am Rev Respir Dis 138 (1988) 1103
41. Dauber I.M., Lesnefsky E.J., Ashmore R.C., et al. Coronary vascular injury due to ischemia reperfusion is reduced by pentoxifylline. J Pharmacol Exp Ther 260 (1992) 1250
42. Bessler H., Gilgal R., Djaldetti M., and Zahavi I. Effect of pentoxifylline on phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol 40 (1986) 747
43. Coe D.A., Freischlag J.A., Johnson D., et al. Pentoxifylline prevents endothelial damage due to ischemia reperfusion injury. J Surg Res 67 (1997) 21
44. Gale S.C., Hokama J.Y., Ritter L.S., Gorman G.D., Copeland J.G., and McDonagh P.F. Pnetoxifylline reduces coronary leukocyte accumulation early in reperfusion after cold ischemia. Ann Thorac Surg 71 (2001) 1305
45. Savaş C., Aras T., Cakmak M., et al. entoxifylline inhibits overflow and reduces intestinal reperfusion injury. J Ped Surg 32 (1997) 905
46. Clark S.C., Rao J.N., Flecknell P.A., and Dark J.H. Pentoxifylline is as effective as leukocyte depletion for modulating pulmonary injury. J Thorac Cardiovasc Surg 126 (2003) 2052
47. Liu X., Peter W.F., Barker J.H., Pierangeli S.S., Harris E.N., and Anderson G.L. Leukocyte endothelium interaction in arteriols after ischemia reperfusion. J Surg Res 87 (1999) 77
48. Menger M.D., Rucker M., and Vollmar B. Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of "no re-flow". Shock 8 (1997) 2
49. Berkenboom G., Fang Z., Unger P., Goldman M., and Fontaine J. Endothelium dependent effects of pentoxifylline in rat aorta. Eur J Pharmacol 193 (1991) 81
50. Eppihimer M.J., and Granger D.N. Ischemia reperfusion induced leukocyte endothelial interactions in postcapillary venules. Shock 8 (1997) 16
51. Hanazawa S., Prewitt R.L., and Terzis J.L. The effect of pentoxifylline on ischemia reperfusion injury in the rat cremaster muscle. J Reconstr Microsurg 10 (1994) 21